Retatrutide is a groundbreaking treatment for obesity and metabolic health, targeting three key hormone pathways for enhanced effectiveness. It has shown impressive weight loss results in clinical trials, with participants losing up to 24.2% of their body weight in 48 weeks. This makes it a promising alternative to existing treatments like Wegovy and Mounjaro. Additionally, Retatrutide is being studied for its impact on type 2 diabetes, helping to reduce blood sugar levels while promoting significant weight loss.

5 x 4mg vials comes with 11ml bacteriostatic diluent